Top 10 Key Players companies in Diabetic neuropathy by Highest Patent Value in the Germany in 2022 – Discovery

Free Trial

The Diabetic neuropathy top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Diabetic neuropathy Key Players in the Germany. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

1	Bayer Pharma AG	Berlin, Germany	Medicine,Nuclear medicine,Andrology, ...[+2]	Avg patent value: 7.01 M
2	Grünenthal GmbH	Nordrhein-Westfalen, Germany	Medicine,Health care,Clinical trial, ...[+2]	Avg patent value: 880,000
3	Sanofi-Aventis Deutschland GmbH	Hessen, Germany	Biosimilar,Drug,Medicine	Avg patent value: 700,000
4	Aventis Pharma Deutschland GmbH	Hessen, Germany	Medicine,Therapeutic protein,Active ingredient, ...[+2]	Avg patent value: 700,000
5	Merck Serono SA	Hessen, Germany	Biology,Health care,Fertility, ...[+2]	Avg patent value: 470,000
6	Bayer AG	Nordrhein-Westfalen, Germany	Health care,Biology,Chemical engineering, ...[+2]	Avg patent value: 0
7	Bayer HealthCare AG	Nordrhein-Westfalen, Germany	Health care,Diabetes Therapy,Immunoprotein, ...[+2]	Avg patent value: 0
8	BIOPHARM Gesellschaft zur biotechnologischen Entwicklung	Germany	Biotechnology,Growth factor,Personalized medicine, ...[+2]	Avg patent value: 0
9	Merck Patent GmbH	Hessen, Germany		Avg patent value: 0
10	MEDA Pharma GmbH & Co. KG	Hessen, Germany	Medicine,Anticonvulsant,Gabapentin, ...[+2]	Avg patent value: 0